Literature DB >> 7828166

Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction.

J A Barbuto1, W J Grimes, E M Hersh.   

Abstract

Infiltrating B lymphocytes are found within tumors, where their role and the antigens they recognize are poorly defined. After in vitro expansion of these cells, we were able to detect the production of antibodies to tumor necrosis factor alpha (TNF) in 13 of 17 human tumors studied. These antibodies were detected by both enzyme-linked immunosorbent assay and by neutralization. Anti-TNF antibodies were not produced by resting peripheral blood B cells of normal subjects. However, anti-TNF antibodies were produced by B cells obtained from healthy individuals, after either in vivo or in vitro antigenic stimulation. This suggests that anti-TNF antibody production may constitute part of the overall B cell response to antigens. The intratumoral production of anti-TNF antibody may play a role in tumor/host interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7828166     DOI: 10.1007/bf01517233

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  31 in total

1.  Constitutive synthesis of tumor necrosis factor in the thymus.

Authors:  B P Giroir; T Brown; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Cell-surface antigens of melanoma recognized by human monoclonal antibodies.

Authors:  H Yamaguchi; K Furukawa; S R Fortunato; P O Livingston; K O Lloyd; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.

Authors:  H Tsujihashi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  J Urol       Date:  1988-10       Impact factor: 7.450

4.  Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.

Authors:  Y Shimizu; S Iwatsuki; R B Herberman; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Human hybridomas from malignant gliomas.

Authors:  K Sikora; T Alderson; J Phillips; J V Watson
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

6.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

Authors:  R F Irie; L L Sze; R E Saxton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

Authors:  R F Irie; D L Morton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.

Authors:  A S Chong; P Scuderi; W J Grimes; E M Hersh
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

9.  Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors.

Authors:  J Y Blay; J Bertoglio; D Fradelizi; S Chouaib
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

10.  Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

Authors:  R J Barth; J J Mulé; P J Spiess; S A Rosenberg
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.